Drugs / BLI4700
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03023085 | Aug 2016 → Aug 2017 | — | Braintree Laboratories | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT03103581 | Feb → Apr 2017 | — | Braintree Laboratories | Completed | No outcome recorded |
| Phase 32 trials · 1 met primary | ||||||
| Phase 3 | NCT03404401 | Jan → Jul 2018 | — | Braintree Laboratories | Completed | Met primary |
| Phase 3 | NCT03261960 | Aug 2017 → Mar 2018 | — | Braintree Laboratories | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BLI4700 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03103581 ↗ |
| Route | Oral | “Oral bowel preparation” NCT03261960 ↗ |